Abstract. Calcaneus bone mineral density (BMD) of 738 Japanese women (605 healthy and 133 with osteoporosis) was measured using single X-ray absorptiometry (SXA). A reference range of calcaneus BMD values for healthy Japanese women was established and the usefulness of this method for screening and diagnosis of osteoporosis was evaluated. There was no significant age change of calcaneus BMD prior to menopause, though values decreased significantly thereafter. BMD loss ratio was 1.7%/year in the 10 years after menopause.
Currently, with the rapidly increasing population of the elderly in Japan, a simpler measuring method of mass screening for osteoporosis is needed. Though an evaluation of calcaneus bone mass has been done clinically by dual (DXA) and single X-ray absorptiometry (SXA), or ultrasound, few previous reports [1, 2] have focused on the validity of measuring calcaneus BMD by SXA in the Japanese population.
In this study, we used SXA to measure calcaneus BMD in healthy Japanese women and in osteoporosis patients. We established a normal range of calcaneus BMD among the healthy subjects, investigated the influences of various factors on calcaneus BMD, and evaluated the usefulness and reproducibility of the method generally.
Subjects and Methods

Subjects
Subjects consisted of 605 healthy women 20-78 years of age (mean 48.3 years) who participated in osteoporosis screening, and 133 osteoporosis patients 51-96 years of age (mean 72.4 years). Because we planned also to establish a reference range, subjects with a history of any disease that could affect bone metabolism, those with spondylosis, or those who were currently outpatients or inpatients receiving medical treatment were excluded from this study by preliminary questioning. Therefore, subjects under the age of 50 did not have radiographs but were included in the control group. Osteoporosis was defined as the appearance of spine fractures on a radiograph.
Measurements
We measured the right calcaneus BMD of 738 women (605 healthy and 133 osteoporosis patients) using SXA. Among these subjects, spine BMD was measured in 363 healthy women and 57 osteoporosis patients using DXA (DPX-L Lunar, Madison, WI), and radiographs were taken to check spine fractures in 46 healthy women and 133 osteoporosis patients. Informed consent was obtained from all subjects. We established a reference range of calcaneus BMD for the healthy Japanese women from the 605 crosssectional data.
Calcaneus and spine BMD were measured concurrently in 420 cases to examine the correlation between the two measurements and to study the effect of menopause and body size on each. Of 179 cases for which spine radiographs were available, we examined the usefulness of measuring calcaneus BMD by SXA for diagnosing osteoporosis.
Further, in order to study accuracy and reproducibility of this method, we used a phantom for 7 days, then once a month for 6 consecutive months to calculate precision in vitro and subsequently estimate short-and long-term precision. We also measured BMD of the right calcaneus in three healthy and two osteoporotic subjects for 5 consecutive days in order to establish precision in vivo.
Spine Fracture. In the lateral view of thoracic and lumbar spine radiographs, spine fracture was defined using a semiquantitative technique [3] . According to this criteria, fracture cases include grades 1-3 in this study.
Statistical Analysis
Statistical comparisons were made using an unpaired t-test and analysis of variance (ANOVA). The relationship of BMD and age and years since menopause (YSM) were analyzed by liner regression. In each analysis, P < 0.05 was considered statistically significant.
Results
Precision
Precision in vitro was 0.8% CV for the short term and 0.6% CV for the long term, and precision in vivo was 0.8% CV; both precision in vitro and in vivo showed high reproducibility (CV < 1%). Approximately 17% of bone mineral is believed to be lost in the 10 years after menopause.
Age-Related Change of Calcaneus BMD in Normal Japanese Women
No significant difference was found between the decrement patterns of calcaneus and spine BMD after menopause. (Fig. 1) 
Effects of Body Size on Calcaneus BMD
In the 420 cases receiving concurrent measurement of calcaneus and spine BMD, we studied the effects of height and body weight on both measurements. There were significant correlations between calcaneus and spine BMD and height and body weight in these subjects ( Table 2) .
The 420 cases were further divided into three groups: Group A, BMI < 21; Group B, 21 < BMI < 25; Group C, 25 < BMI, for comparison and evaluation of calcaneus BMD. Group A showed significantly lower values than Group C in each age group, and this tendency was stronger in the case of calcaneus BMD than in spine BMD (Table 3) .
Relationship Between Calcaneus BMD and Spine BMD
There was a high correlation between calcaneus BMD measured by SXA and spine BMD measured by DXA in the 420 cases (Spine BMD ‫ס‬ 1.839E-3 × Calcaneus BMD + 0.356; r ‫ס‬ 0.812, S.E. ‫ס‬ 0.022; P < 0.0001) (Fig. 2) .
Calcaneus BMD and Spine Fracture
Among the 179 cases who had had radiographs, 133 showed spine fractures. The 90th centile of calcaneus BMD values in these fracture cases was 294 mg/cm 2 as the fracture threshold for spine, and this value corresponded to −2.67 SD from the average BMD of the young healthy women. When all cases were divided into a spine fracture and nonfracture group, and calcaneus BMD was compared among each age group, the BMD of the fracture group was significantly lower in each age group than that of the nonfracture group (Table 4) .
In the fracture group, Z-scores of calcaneus and spine BMD, calculated from the average BMD values of healthy age-matched women, were −1.01 ± 1.10 and −1.03 ± 0.876, respectively. Areas under the curve in the ROC analysis for Table 1 . Age-related change of calcaneus bone mineral density using single X-ray absorptiometry in normal Japanese women. The peak bone mass was in the 20-24 age group, and there was significant decrease among the 50-54, 55-59, and 60-64 age groups. spine fracture were 0.70 ± 0.07 and 0.72 ± 0.07, respectively. There were no significant differences between the two measuring methods in terms of Z-score or area under the curve. T-scores calculated from the average BMD values of young healthy women were −3.97 ± 1.23 and −2.93 ± 0.86; significant differences (P < 0.001) were shown between calcaneus BMD and spine BMD.
Discussion
The calcaneus is generally recognized as an appropriate site for the measurement of BMD because it is composed of cancellous bone and because it sensitively reflects BMD changes in bone metabolic disease, particularly those associated with osteoporosis [4] . Regarding the annual decrement ratio of calcaneus BMD with increasing age, Steiger et al. [5] , Lancaster et al. [6] , and Harris and Dawson-Hughes [7] reported it to be approximately 1%, Davis et al. [8] reported it to be approximately 2%, and Hoshi et al. [1, 2] reported it to be 1.72 or 2.5% during perimenopause Japanese women. Our present result of 1.7% was almost the same as what Hoshi reported and the greater changes of annual BMD loss were observed in both Japanese cross-sectional data. On the other hand, Kotzki et al. [9] or Laval-Jeantet et al. [10] indicated that Fig. 1 . After menopause, calcaneus BMD decreased 1.7% per year, and no significant differences were seen between calcaneus relative to BMD (calculated from the mean BMD of premenopausal women) and that of the spine. It seemed that both calcaneus and spine BMD decreased after menopause in the same pattern. N.S. ‫ס‬ nonsignificant. BMD loss in the calcaneus was slight or less than that in the spine. Several reports [11] [12] [13] [14] indicated that that osteoporosis may be more common in oriental or Japanese populations than in Caucasians, and that may be caused by racial or environmental factors.
In the case of cross-sectional data, many factors may affect these various results. Methods for evaluating BMD with various precisions, nutritional conditions, body-size, physical activity of subjects, and racial differences should be considered in the study. In addition, Pacifici et al. [15] reported that even in a longitudinal study, the existence of fat mass can lead to an error in results.
Many reports indicated that weight or physical activity strongly affect calcaneus BMD [12, 16, 17] . With regard to the calcaneus as a weight-bearing bone, Vogel et al. [4] reported that the correlation coefficients between body weight and calcaneus or spine BMD were 0.492 or 0.423, and since these values are roughly equivalent, the calcaneus was not uniquely influenced by body weight. In our study, we also found that the correlation between calcaneus BMD and body weight (0.461, P < 0.001) was similar to that between spine BMD and body weight (0.427, P < 0.001). From the viewpoint of body mass index (BMI), however, it seemed that body size affected calcaneus BMD more strongly than spine BMD.
In addition, in our study as well as in previous studies, a high correlation was observed between calcaneus BMD and spine BMD [4, 18, 19] , mainly because the calcaneus and the spine have similar metabolisms, are both weight-bearing bones, and both are composed mainly of cancellous bone.
Conventionally it is held that the fracture risk of the forearm, spine, and hip are most effectively evaluated by directly measuring BMD in the corresponding site. However, some reports have indicated that the same evaluation is possible by measuring BMD of appendicular bones not located at the bone fracture site [20] [21] [22] [23] [24] [25] . Wasnich et al. [26] and Vogel et al. [4] reported that the measurement of calcaneus BMD was more useful than that of spine BMD for evaluating the risk of spine fracture. In our study, the calcaneus BMD measured by SXA showed a high correlation with the spine BMD by DXA; further, no significant differences between these two methods were observed in ROC analysis for spine fracture. We therefore concluded that measurement of calcaneus BMD using SXA has almost the same value in screening for osteoporosis as that of spine BMD using DXA.
Riggs et al. [27] defined the fracture threshold as the value that includes 90% of fracture cases, i.e., the 90th percentile value. In our study, the 90th percentile value of 133 spine fracture cases (calcaneus BMD:294 mg/cm 2 ) corresponded to −2.67 SD from the average BMD of the young healthy women. In the case of a BMD lower than this value, the odds ratio for spine fracture was 3.52 (95% CI:1.34-9.26).
In 1994, the WHO defined in its reports [28, 29] that regardless of whether the measurement site is the hip, spine, or wrist, BMD values of greater than −1 SD from the average values of the young healthy subjects are defined as normal, values of −1 SD to −2.5 SD are defined as osteopenia, and values of less than −2.5 SD are defined as osteoporosis. When −2.5 SD is the cutoff line, approximately 30% of postmenopausal women can be extracted, a percentage nearly comparable to the remaining lifetime fracture risk (30-40%) of women in their 50s [30] . When these criteria are applied to the calcaneus BMD of our subjects, 36.2% of women in their 50s, 28.9% in their 60s, and 7.1% in their 70s are diagnosed as having osteopenia; 28.6% of women in their 50s, 60.8% in their 60s, and 92.8% in their 70s are diagnosed as having osteoporosis. A cumulative 41.6% of all women over 50 are extracted to have a fracture risk (sensitivity 92.5%, specificity 76.5%).
When our fracture threshold is used as the cutoff value, 24.1% of women in their 50s, 54.6% in their 60s, 92.8% in their 70s, and a cumulative 36.8% of all women over 50 years old are extracted (specificity 79.3%) to have fracture risk (Fig. 3) . If the remaining lifetime fracture risk of Japanese women ranges from 30 to 40%, our fracture threshold may be suitable for a cutoff value in diagnosing osteoporosis because of its odds ratio for spine fracture or extraction rate for patients with fracture risk. In diagnosing osteoporosis, −2.5 SD as a cutoff value of WHO is based on the value that identified the lowest quintile (20%) of postmenopausal women. The value, in this study that extracts 20% of postmenopausal women is −3.8 SD and is equivalent to the 65th percentile of the fracture group, i.e., break point (specificity 97.3%).
However, the fact that many normal women are below the fracture threshold indicates that there is a substantial overlap; also, that not all osteoporotic risk factors are expressed via bone mass [31] . The WHO report states that because of the continuous distribution of bone density, there is no true fracture threshold, or as Mazess [32] expressed it, "Osteoporosis is difficult to define because of the gradient of risk, but operationally there is a need to isolate a population subset with bone density low enough to exclude at least two-thirds of nonfracture cases and yet high enough to include most fracture cases."
Recently, various risk factors have been studied in evaluating fracture risk in osteoporosis. It has been considered that 80-90% of bone strength depends on BMD [32] , such that fracture risk has been explained mostly in terms of this index. In our study as well, low BMD of the calcaneus indicated an increased fracture risk, but it must also be considered that for each site of evaluation there are various decrement ratios of BMD after menopause [5, 33] , as well as heterogeneity of BMD [34] .
After menopause, calcaneus BMD decreased with a pattern similar to that of spine BMD, but was comparatively more strongly affected by body size. In evaluating BMD at the site of the calcaneus, it is important to bear in mind that certain local factors such as body size or exercise may affect the measurement. In conclusion, in our study, calcaneus BMD sensitively reflected the BMD change after menopause, and low BMD of the calcaneus indicated an increased fracture risk. We believe that BMD measurement at the calcaneus using the SXA method is comparably accurate to BMD measurement by conventional methods. 3 . Distribution (%) of normal, osteopenia, and osteoporosis in Japanese women according to the criteria defined by WHO. In this case, using a cutoff value of −2.67 SD (fracture threshold), 36.8% of all subjects older than 50 could be screened.
